In Re Glumetza Antitrust Litigation

Good Law
United States District Court, Northern District of CaliforniaDecember 5, 20203:19-cv-05822California1,701 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

In re No. C 19-05822 WHA GLUMETZA ANTITRUST No. C 19-06138 WHA LITIGATION. No. C 19-06839 WHA No. C 19-07843 WHA No. C 19-08155 WHA No. C 20-01198 WHA This Document Relates to: No. C 20-05251 WHA 12 HUMANA ACTION. (Consolidated)

ORDER RE MOTION

TO DISMISS HUMANA

COMPLAINT

15 INTRODUCTION Eleven months into this antitrust lawsuit, months into discovery, and on the eve of class certification, a new plaintiff seeks to join the recovery. The complaint failing to adequately plead the location of the purchases, standing to raise state claims remains speculative. The motion to dismiss is GRANTED IN PART. STATEMENT Prior orders detail the underlying allegations (Dkt. Nos. 188, 347). Simply put, our plaintiffs allege that defendants, prime among them, Bausch Health Companies Inc., Lupin 24 …

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.